Prenatal Care: Touching the Future

Primary Care - Clinics in Office Practice

Volumn 39, Issue 1, 2012, Pages 17-37

  Dooley, Erin Kate ^a   Ringler, Robert L ^b,c  

^a Medicos para la Familia   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Department of Family and Community Medicine ^*  (United States)

Author keywords

Antenatal; Patient education; Preconception; Pregnancy; Prenatal; Testing and screening

Indexed keywords

CALCIUM; CEFAZOLIN; CLINDAMYCIN; FOLIC ACID; HEMOGLOBIN; IRON; MULTIVITAMIN; PENICILLIN G; RHESUS ANTIBODY; VANCOMYCIN; VITAMIN D;

ALCOHOL CONSUMPTION; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIBODY SCREENING; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIURIA; BLOOD CELL COUNT; BLOOD GROUP TYPING; BODY MASS; BREAST FEEDING; CIRCUMCISION; DELIVERY; DIET SUPPLEMENTATION; DRUG USE; ECHOGRAPHY; ELECTROPHORESIS; EMPLOYMENT; EPIDURAL ANESTHESIA; FETUS RISK; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; GESTATIONAL AGE; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HUMAN; IMMUNIZATION; INTIMATE PARTNER VIOLENCE; LABOR; LABORATORY TEST; LOW BACK PAIN; LOW BIRTH WEIGHT; MATERNAL CARE; MEDICAL HISTORY; NEURAL TUBE DEFECT; NEWBORN CARE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARTNER VIOLENCE; PATIENT COUNSELING; PATIENT EDUCATION; PELVIS PAIN SYNDROME; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RECOMMENDED DRUG DOSE; REVIEW; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCUS AGALACTIAE; THIRD TRIMESTER PREGNANCY; URINALYSIS; VACCINATION; WEIGHT GAIN; ATTITUDE TO HEALTH; DIRECTIVE COUNSELING; FEMALE; FETUS ECHOGRAPHY; HEALTH PROMOTION; MATERNAL WELFARE; METHODOLOGY; PATIENT REFERRAL; PREGNANCY;

DIRECTIVE COUNSELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MATERNAL WELFARE; PATIENT EDUCATION AS TOPIC; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; REFERRAL AND CONSULTATION; ULTRASONOGRAPHY, PRENATAL;

EID: 84856574568     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2011.11.002     Document Type: Review

References (136)

1. ACOG Committee on Obstetric Practice Committee opinion: number 264, December 2001. Air travel during pregnancy. Obstet Gynecol 2001, 98(6):1187-1188.
2. Boss D.J., Timbrook R.E. Clinical obstetric outcomes related to continuity in prenatal care. JAm Board Fam Pract 2001, 14(6):418-423.
3. Alexander G.R., Kotelchuck M. Assessing the role and effectiveness of prenatal care: history, challenges, and directions for future research. Public Health Rep 2001, 116(4):306-316.
4. Kogan M.D., Martin J.A., Alexander G.R., et al. The changing pattern of prenatal care utilization in the United States, 1981-1995, using different prenatal care indices. JAMA 1998, 279(20):1623-1628.
5. Alexander G.R., Kogan M.D., Nabukera S. Racial differences in prenatal care use in the United States: are disparities decreasing?. Am J Public Health 2002, 92(12):1970-1975.
6. Markovitz B.P., Cook R., Flick L.H., et al. Socioeconomic factors and adolescent pregnancy outcomes: distinctions between neonatal and post-neonatal deaths?. BMC Public Health 2005, 5:79.
7. Bennett I., Switzer J., Aguirre A., et al. 'Breaking it down': patient-clinician communication and prenatal care among African American women of low and higher literacy. Ann Fam Med 2006, 4(4):334-340.
8. Yu S.M., Alexander G.R., Schwalberg R., et al. Prenatal care use among selected Asian American groups. Am J Public Health 2001, 91(11):1865-1868.
9. Braveman P., Marchi K., Egerter S., et al. Barriers to timely prenatal care among women with insurance: the importance of prepregnancy factors. Obstet Gynecol 2000, 95(6 Pt 1):874-880.
10. Goldenberg R.L., Patterson E.T., Freese M.P. Maternal demographic, situational and psychosocial factors and their relationship to enrollment in prenatal care: a review of the literature. Women Health 1992, 19(2-3):133-151.
11. Lia-Hoagberg B., Rode P., Skovholt C.J., et al. Barriers and motivators to prenatal care among low-income women. Soc Sci Med 1990, 30(4):487-495.
12. Poland M.L., Ager J.W., Olson J.M. Barriers to receiving adequate prenatal care. Am J Obstet Gynecol 1987, 157(2):297-303.
13. Fiscella K. Does prenatal care improve birth outcomes? A critical review. Obstet Gynecol 1995, 85(3):468-479.
14. Health Care Guideline: Routine Prenatal Care 2010, Institute for Clinical Systems Improvement, Fourteenth. Available at:, Accessed April 14, 2011. http://www.icsi.org/prenatal_care_4/prenatal_care__routine__full_version__2.html.
15. Kirkham C., Harris S., Grzybowski S. Evidence-based prenatal care: Part I. General prenatal care and counseling issues. Am Fam Physician 2005, 71(7):1307-1316.
16. Bronstein J.M., Felix H.C., Bursac Z., et al. Providing general and preconception health care to low income women in family planning settings: perception of providers and clients. Matern Child Health J 2011, Availale at:, Accessed November 2, 2011. http://www.springerlink.com/content/g4173m6653464754/.
17. Brennan M. Pre-pregnancy care for diabetes. Pract Midwife 2010, 13(11):16. 18-9.
18. Witters I., Bogaerts A., Fryns J.P. Preconception care. Genet Couns 2010, 21(2):169-182.
19. Heavey E. Don't miss preconception care opportunities for adolescents. MCN Am J Matern Child Nurs 2010, 35(4):213-219.
20. Das S., Rao V., Chaudhuri J.D. Preconception counseling in the prevention of fetal alcohol syndrome: a unique window of opportunity. Clin Ter 2009, 160(4):315-322.
21. Carl J., Hill D.A. Preconception counseling: make it part of the annual exam. JFam Pract 2009, 58(6):307-314.
22. Solomon B.D., Jack B.W., Feero W.G. The clinical content of preconception care: genetics and genomics. Am J Obstet Gynecol 2008, 199(6 Suppl 2):S340-S344.
23. Elsinga J., de Jong-Potjer L.C., van der Pal-de Bruin K.M., et al. The effect of preconception counselling on lifestyle and other behaviour before and during pregnancy. Womens Health Issues 2008, 18(Suppl 6):S117-S125.
24. Hillemeier M.M., Weisman C.S., Chase G.A., et al. Women's preconceptional health and use of health services: implications for preconception care. Health Serv Res 2008, 43(1 Pt 1):54-75.
25. Tough S.C., Clarke M., Clarren S. Preventing fetal alcohol spectrum disorders. Preconception counseling and diagnosis help. Can Fam Physician 2005, 51:1199-1201.
26. Gardiner P.M., Nelson L., Shellhaas C.S., et al. The clinical content of preconception care: nutrition and dietary supplements. Am J Obstet Gynecol 2008, 199(6Suppl 2):S345-S356.
27. Wilson R.D., Johnson J.A., Wyatt P., et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. JObstet Gynaecol Can 2007, 29(12):1003-1026.
28. Lipscombe L.L., McLaughlin H.M., Wu W., et al. Pregnancy planning in women with pregestational diabetes. JMatern Fetal Neonatal Med 2011, 24(9):1095-1101.
29. Slocum J., Barcio L., Darany J., et al. Preconception to postpartum: management of pregnancy complicated by diabetes. Diabetes Educ 2004, 30(5):740. 742-4, 747-53.
30. Crocker A., Farrell T. Pregnancy and pre-existing diabetes: key concerns. Hosp Med 2004, 65(6):351-354.
31. American College of Obstetricians and Gynecologists, Committee on Professional Standards Standards for obstetric-gynecologic hospital services. Standards for obstetric-gynecologic services 1985, American College of Obstetricians and Gynecologists, Washington, DC. 6th edition.
32. Huntington J., Connell F.A. For every dollar spent-the cost-savings argument for prenatal care. NEngl J Med 1994, 331(19):1303-1307.
33. Carroli G., Villar J., Piaggio G., et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet 2001, 357(9268):1565-1570.
34. Clement S., Candy B., Sikorski J., et al. Does reducing the frequency of routine antenatal visits have long term effects? Follow up of participants in a randomised controlled trial. Br J Obstet Gynaecol 1999, 106(4):367-370.
35. Villar J., Khan-Neelofur D. Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev 2000, 2. CD000934.
36. American Academy of Pediatrics, American College of Obstetricians and Gynecologists March of Dimes Birth Defects Foundation. Guidelines for perinatal care 2007, American Academy of Pediatrics; American College of Obstetricians and Gynecologists, Elk Grove Village (IL), Washington, DC, xiv, p. 450. 6th edition.
37. National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman, 2008. Availale at: Accessed November 2, 2011. http://www.nice.org.uk/nicemedia/live/11947/40145/40145.pdf.
38. McLean E., Cogswell M., Egli I., et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009, 12(4):444-454.
39. Lops V.R., Hunter L.P., Dixon L.R. Anemia in pregnancy. Am Fam Physician 1995, 51(5):1189-1197.
40. Msolla M.J., Kinabo J.L. Prevalence of anaemia in pregnant women during the last trimester. Int J Food Sci Nutr 1997, 48(4):265-270.
41. Bayoumeu F., Subiran-Buisset C., Baka N.E., et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 2002, 186(3):518-522.
42. Reveiz L., Gyte G.M., Cuervo L.G. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2007, 2. CD003094.
43. Tsianakas V., Calnan M., Atkin K., et al. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of GPs' experiences. Br J Gen Pract 2010, 60(580):822-828.
44. Dormandy E., Gulliford M., Bryan S., et al. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ 2010, 341:c5132.
45. Rogers D.T., Molokie R. Sickle cell disease in pregnancy. Obstet Gynecol Clin North Am 2010, 37(2):223-237.
46. Krcmery S., Hromec J., Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 2001, 17(4):279-282.
47. Murray N., Homer C.S., Davis G.K., et al. The clinical utility of routine urinalysis in pregnancy: a prospective study. Med J Aust 2002, 177(9):477-480.
48. Rouse D.J., Andrews W.W., Goldenberg R.L., et al. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstet Gynecol 1995, 86(1):119-123.
49. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51(RR-6):1-78.
50. Nelson H.D., Helfand M. Screening for chlamydial infection. Am J Prev Med 2001, 20(Suppl 3):95-107.
51. Hong F.C., Liu J.B., Feng T.J., et al. Congenital syphilis: an economic evaluation of a prevention program in China. Sex Transm Dis 2010, 37(1):26-31.
52. Johnson H.L., Ghanem K.G., Zenilman J.M., et al. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm Dis 2011, 38(3):167-171.
53. Kirkham C., Harris S., Grzybowski S. Evidence-based prenatal care: part II. Third-trimester care and prevention of infectious diseases. Am Fam Physician 2005, 71(8):1555-1560.
54. Hofmeyr G.J., Lawrie T.A., Atallah A.N., et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010, 8. CD001059.
55. Sibai B.M. Calcium supplementation during pregnancy reduces risk of high blood pressure, pre-eclampsia and premature birth compared with placebo?. Evid Based Med 2011, 16(2):40-41.
56. Anwar A., Salih A., Masson E., et al. The effect of pre-pregnancy counselling for women with pre-gestational diabetes on maternal health status. Eur J Obstet Gynecol Reprod Biol 2011, 155(2):137-139.
57. Spinillo A., Capuzzo E., Piazzi G., et al. Risk for spontaneous preterm delivery by combined body mass index and gestational weight gain patterns. Acta Obstet Gynecol Scand 1998, 77(1):32-36.
58. Rasmussen T., Stene L.C., Samuelsen S.O., et al. Maternal BMI before pregnancy, maternal weight gain during pregnancy, and risk of persistent positivity for multiple diabetes-associated autoantibodies in children with the high-risk HLA genotype: the MIDIA study. Diabetes Care 2009, 32(10):1904-1906.
59. Saftlas A., Wang W., Risch H., et al. Prepregnancy body mass index and gestational weight gain as risk factors for preeclampsia and transient hypertension. Ann Epidemiol 2000, 10(7):475.
60. Langer O., Yogev Y., Xenakis E.M., et al. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol 2005, 192(6):1768-1776.
61. Robinson H.E., O'Connell C.M., Joseph K.S., et al. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol 2005, 106(6):1357-1364.
62. Ju H., Rumbold A.R., Willson K.J., et al. Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy Childbirth 2008, 8:31.
63. Ouzounian J.G., Hernandez G.D., Korst L.M., et al. Pre-pregnancy weight and excess weight gain are risk factors for macrosomia in women with gestational diabetes. JPerinatol 2011, 31(11):717-721.
64. Heude B., Thiebaugeorges O., Goua V., et al. Pre-pregnancy body mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension, and birth outcomes. Matern Child Health J 2011, Available at:, Accessed November 2, 2011. http://www.mendeley.com/research/prepregnancy-body-mass-index-weight-gain-during-pregnancy-relations-gestational-diabetes-hypertension-birth-outcomes/.
65. Chang G., McNamara T.K., Orav E.J., et al. Brief intervention for prenatal alcohol use: a randomized trial. Obstet Gynecol 2005, 105(5 Pt 1):991-998.
66. O'Connor M.J., Whaley S.E. Brief intervention for alcohol use by pregnant women. Am J Public Health 2007, 97(2):252-258.
67. Lu M.C., Tache V., Alexander G.R., et al. Preventing low birth weight: is prenatal care the answer?. JMatern Fetal Neonatal Med 2003, 13(6):362-380.
68. Khoury J.C., Miodovnik M., Buncher C.R., et al. Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. JMatern Fetal Neonatal Med 2004, 15(1):44-50.
69. ACOG Committee on Health Care for Underserved Women, ACOG Committee on Obstetric Practice ACOG committee opinion. Number 316, October 2005. Smoking cessation during pregnancy. Obstet Gynecol 2005, 106(4):883-888.
70. Rosenthal A.C., Melvin C.L., Barker D.C. Treatment of tobacco use in preconception care. Matern Child Health J 2006, 10(Suppl 5):S147-S148.
71. Little B.B., Snell L.M., Van Beveren T.T., et al. Treatment of substance abuse during pregnancy and infant outcome. Am J Perinatol 2003, 20(5):255-262.
72. Ebrahim S.H., Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003, 101(2):374-379.
73. Miles D.R., Lanni S., Jansson L., et al. Smoking and illicit drug use during pregnancy: impact on neonatal outcome. JReprod Med 2006, 51(7):567-572.
74. Ludlow J., Christmas T., Paech M.J., et al. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intensive Care 2007, 35(6):881-893.
75. Kuczkowski K.M. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007, 19(6):578-585.
76. Domenici C., Cuttano A., Nardini V., et al. Drug addiction during pregnancy: correlations between the placental health and the newborn's outcome-elaboration of a predictive score. Gynecol Endocrinol 2009, 25(12):786-792.
77. Keegan J., Parva M., Finnegan M., et al. Addiction in pregnancy. JAddict Dis 2010, 29(2):175-191.
78. Moore D.G., Turner J.D., Parrott A.C., et al. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. JPsychopharmacol 2010, 24(9):1403-1410.
79. de Moraes Barros M.C., Guinsburg R., de Araujo Peres C., et al. Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. JPediatr 2006, 149(6):781-787.
80. Dawes M.G., Grudzinskas J.G. Repeated measurement of maternal weight during pregnancy. Is this a useful practice?. Br J Obstet Gynaecol 1991, 98(2):189-194.
81. Brown H.L. Trauma in pregnancy. Obstet Gynecol 2009, 114(1):147-160.
82. O'Reilly R., Beale B., Gillies D. Screening and intervention for domestic violence during pregnancy care: a systematic review. Trauma Violence Abuse 2010, 11(4):190-201.
83. Renker P.R., Tonkin P. Women's views of prenatal violence screening: acceptability and confidentiality issues. Obstet Gynecol 2006, 107(2 Pt 1):348-354.
84. Shah P.S., Shah J. Maternal exposure to domestic violence and pregnancy and birth outcomes: a systematic review and meta-analyses. JWomens Health (Larchmt) 2010, 19(11):2017-2031.
85. Gielen A.C., Faden R.R., O'Campo P., et al. Women's protective sexual behaviors: a test of the health belief model. AIDS Educ Prev 1994, 6(1):1-11.
86. Klebanoff M.A., Shiono P.H., Carey J.C. The effect of physical activity during pregnancy on preterm delivery and birth weight. Am J Obstet Gynecol 1990, 163(5 Pt 1):1450-1456.
87. Berkowitz G.S. Employment-related physical activity and pregnancy outcome. JAm Med Womens Assoc 1995, 50(5):167-169. 174.
88. Luke B., Mamelle N., Keith L., et al. The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association of Women's Health, Obstetric, and Neonatal Nurses. Am J Obstet Gynecol 1995, 173(3 Pt 1):849-862.
89. Peoples-Sheps M.D., Siegel E., Suchindran C.M., et al. Characteristics of maternal employment during pregnancy: effects on low birthweight. Am J Public Health 1991, 81(8):1007-1012.
90. Neilson J.P. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev 2000, 2. CD000944.
91. Gribble R.K., Fee S.C., Berg R.L. The value of routine urine dipstick screening for protein at each prenatal visit. Am J Obstet Gynecol 1995, 173(1):214-217.
92. Comstock C.H., Malone F.D., Ball R.H., et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?. Am J Obstet Gynecol 2006, 195(3):843-847.
93. Taslimi M.M., Acosta R., Chueh J., et al. Detection of sonographic markers of fetal aneuploidy depends on maternal and fetal characteristics. JUltrasound Med 2005, 24(6):811-815.
94. Agarwal M.M., Dhatt G.S., Shah S.M. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010, 33(9):2018-2020.
95. Bhattacharya S.M. Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools for gestational diabetes mellitus developing in later months of pregnancy. JObstet Gynaecol Res 2004, 30(4):333-336.
96. Bito T., Nyari T., Kovacs L., et al. Oral glucose tolerance testing at gestational weeks < or=16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group. Eur J Obstet Gynecol Reprod Biol 2005, 121(1):51-55.
97. Chatzi L., Plana E., Pappas A., et al. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab 2009, 35(6):490-494.
98. Nahum G.G., Wilson S.B., Stanislaw H. Early-pregnancy glucose screening for gestational diabetes mellitus. JReprod Med 2002, 47(8):656-662.
99. Seshiah V., Cynthia A., Balaji V., et al. Detection and care of women with gestational diabetes mellitus from early weeks of pregnancy results in birth weight of newborn babies appropriate for gestational age. Diabetes Res Clin Pract 2008, 80(2):199-202.
100. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007, 110(6):1459-1467.
101. Bornstein E., Lenchner E., Donnenfeld A., et al. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment. Am J Obstet Gynecol 2010, 203(4):391. e391-5.
102. South S.T., Chen Z., Brothman A.R. Genomic medicine in prenatal diagnosis. Clin Obstet Gynecol 2008, 51(1):62-73.
103. Crane J.P., LeFevre M.L., Winborn R.C., et al. Arandomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994, 171(2):392-399.
104. Whitworth M., Bricker L., Neilson J.P., et al. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev 2010, 4. CD007058.
105. Summaries for patients. Screening for gestational diabetes during pregnancy: recommendation from the U.S. Preventive Services Task Force. Ann Intern Med 2008, 148(10):I60.
106. U.S. Preventive Services Task Force Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 148(10):759-765.
107. Blatt A.J., Nakamoto J.M., Kaufman H.W. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol 2011, 117(1):61-68.
108. Carr C.A. Evidence-based diabetes screening during pregnancy. JMidwifery Womens Health 2001, 46(3):152-158.
109. Lu G.C., Luchesse A., Chapman V., et al. Screening for gestational diabetes mellitus in the subsequent pregnancy: is it worthwhile?. Am J Obstet Gynecol 2002, 187(4):918-921.
110. Maegawa Y., Sugiyama T., Kusaka H., et al. Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 2003, 62(1):47-53.
111. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69.
112. Dashora U., Dashora V., Kennedy L. Two-hour 75-g oral glucose tolerance test early in pregnancy detects most cases of gestational diabetes. Diabetes Care 2002, 25(4):803. [author reply: 804].
113. de Sereday M.S., Damiano M.M., Gonzalez C.D., et al. Diagnostic criteria for gestational diabetes in relation to pregnancy outcome. JDiabetes Complications 2003, 17(3):115-119.
114. Hadar E., Hod M. Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Ann N Y Acad Sci 2010, 1205:88-93.
115. Serlin D.C., Lash R.W. Diagnosis and management of gestational diabetes mellitus. Am Fam Physician 2009, 80(1):57-62.
116. Crowther C.A., Hiller J.E., Moss J.R., et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. NEngl J Med 2005, 352(24):2477-2486.
117. Trolle B. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand 1989, 68(1):45-47.
118. Young G., Jewell D. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev 2002, 1. CD001139.
119. Murtagh J. Female sexual function, dysfunction, and pregnancy: implications for practice. JMidwifery Womens Health 2010, 55(5):438-446.
120. Katz A. Sexually speaking: sexual changes during and after pregnancy. Am J Nurs 2010, 110(8):50-52.
121. Crume T.L., Ogden L., Maligie M., et al. Long-term impact of neonatal breastfeeding on childhood adiposity and fat distribution among children exposed to diabetes in utero. Diabetes Care 2011, 34(3):641-645.
122. Khresheh R., Suhaimat A., Jalamdeh F., et al. The effect of a postnatal education and support program on breastfeeding among primiparous women: a randomized controlled trial. Int J Nurs Stud 2011, 48(9):1058-1065.
123. Monica K.C., du Plessis R.A. Discussion of the health benefits of breastfeeding within small groups. Community Pract 2011, 84(1):31-34.
124. Murtagh L., Moulton A.D. Working mothers, breastfeeding, and the law. Am J Public Health 2011, 101(2):217-223.
125. Oddy W.H., Li J., Whitehouse A.J., et al. Breastfeeding duration and academic achievement at 10 years. Pediatrics 2011, 127(1):e137-e145.
126. Hoddinott P., Tappin D., Wright C. Breast feeding. BMJ 2008, 336(7649):881-887.
127. Vincent R.D., Chestnut D.H. Epidural analgesia during labor. Am Fam Physician 1998, 58(8):1785-1792.
128. Centers for Disease Control and Prevention Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001, 50(RR-19):63-85. [quiz: CE61-19a62-CE66-19a62].
129. U.S. Preventive Services Task Force Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009, 150(10):705-709.
130. Centers for Disease Control and Prevention (CDC) Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009, 58(14):362-365.
131. Verani J.R., McGee L., Schrag S.J., et al. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010 2010, Dept. of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA).
132. Mangesi L., Hofmeyr G.J. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev 2007, 1. CD004909.
133. Circumcision policy statement. American Academy of Pediatrics. Task Force on Circumcision. Pediatrics 1999, 103(3):686-693.
134. Wisner K.L., Parry B.L., Piontek C.M. Clinical practice. Postpartum depression. NEngl J Med 2002, 347(3):194-199.
135. Chandra P.S., Sudhir P. Post-partum depression. Br J Psychiatry 2006, 188:84. [author reply: 84-5].
136. Hannah P., Adams D., Lee A., et al. Links between early post-partum mood and post-natal depression. Br J Psychiatry 1992, 160:777-780.